Henry Hsu, MD, and CEO of Allysta Pharma, talks about the unmet needs of dry eye and ALY688’s promise for treating symptoms of the disease as it heads into a phase 1/2a study.
Henry Hsu, MD speaks for Allysta Pharmaceuticals during the Innovative Showcase at OIS@AAO 2019.
REGISTER for our next ophthalmology conference today.
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.